{"id":{"repo_id":"dominican","oai_identifier":"oai:scholar.dominican.edu:masters-theses-1182"},"canonical_url":"https://search.dev.ndltd.org/etd/dominican/oai:scholar.dominican.edu:masters-theses-1182","repository":{"repo_id":"dominican","name":"Dominican University of California","base_url":"https://scholar.dominican.edu/do/oai/"},"display":{"title":"Modeling Uric Acid Kidney Stones Disease in D. melanogaster using RNAi and Dietary Modulation","abstract":"<p>In humans, the major predictor for gout and forming uric acid kidney stones is elevated uric acid in the serum and urine respectively. It is known that uric acid is an end metabolite of purine degradation in humans, but in other species from <em>D. melanogaster </em>to lower apes,<em> </em>uric acid can be further metabolized by urate oxidase into readily excreted allantoin. We hypothesize that if urate oxidase enzyme activity and dietary purine are both critical in uric acid kidney stone formation, then urate oxidase knockdown in combination with dietary purine supplementation will increase uric acid and induce uric acid kidney stone formation in <em>D. melanogaster</em>. Initially, we confirmed urate oxidase knockdown and then elevation of uric acid as a consequence. We then confirmed uric acid kidney stones formed as a consequence of urate oxidase knocked down and a high purine diet. Next, we tested compounds used to treat gout or uric acid kidney stones in humans using our model. We found that allopurinol and potassium citrate reduced uric acid kidney stone formation in our model. We then tested whether compounds predicted to reduce uric acid and uric acid kidney stones in humans, but not currently used as treatments, can reduce uric acid kidney stone formation in our model. We found that methotrexate, hydrochlorothiazide, and l-lysine were effective at reducing uric acid kidney stone formation. Lastly, we ran a medium throughput screen of 117 natural compounds for inhibitors of uric acid kidney stone formation using our model and found seven inhibitors.</p>","abstract_html":"&lt;p&gt;In humans, the major predictor for gout and forming uric acid kidney stones is elevated uric acid in the serum and urine respectively. It is known that uric acid is an end metabolite of purine degradation in humans, but in other species from &lt;em&gt;D. melanogaster &lt;/em&gt;to lower apes,&lt;em&gt; &lt;/em&gt;uric acid can be further metabolized by urate oxidase into readily excreted allantoin. We hypothesize that if urate oxidase enzyme activity and dietary purine are both critical in uric acid kidney stone formation, then urate oxidase knockdown in combination with dietary purine supplementation will increase uric acid and induce uric acid kidney stone formation in &lt;em&gt;D. melanogaster&lt;/em&gt;. Initially, we confirmed urate oxidase knockdown and then elevation of uric acid as a consequence. We then confirmed uric acid kidney stones formed as a consequence of urate oxidase knocked down and a high purine diet. Next, we tested compounds used to treat gout or uric acid kidney stones in humans using our model. We found that allopurinol and potassium citrate reduced uric acid kidney stone formation in our model. We then tested whether compounds predicted to reduce uric acid and uric acid kidney stones in humans, but not currently used as treatments, can reduce uric acid kidney stone formation in our model. We found that methotrexate, hydrochlorothiazide, and l-lysine were effective at reducing uric acid kidney stone formation. Lastly, we ran a medium throughput screen of 117 natural compounds for inhibitors of uric acid kidney stone formation using our model and found seven inhibitors.&lt;/p&gt;","abstract_has_math":false,"creators":["Lu, Hai T.H."],"institution":null,"degree_name":"Master of Science","degree_level":"Master's Thesis","degree_discipline":"Biological Sciences","degree_department":null,"school":null,"contributors":["Pankah Kapahi, PhD","Roland Cooper, PhD"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2015,"date_issued":"2015-05-01T07:00:00Z","date_published":"2015-05-01T07:00:00Z","updated_at":"2026-07-24T02:04:35Z","subjects":["uric acid kidney stones","nephrolithiasis","biomineralization","purine metabolism","drosophila melanogaster","translational animal model","Integrative Biology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://scholar.dominican.edu/masters-theses/178","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Pankah Kapahi, PhD","Roland Cooper, PhD"]},{"key":"dc:creator","label":"Author","values":["Lu, Hai T.H."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2019-05-14T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biological Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Master's Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["uric acid kidney stones","nephrolithiasis","biomineralization","purine metabolism","drosophila melanogaster","translational animal model","Integrative Biology"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://scholar.dominican.edu/masters-theses/178"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p>In humans, the major predictor for gout and forming uric acid kidney stones is elevated uric acid in the serum and urine respectively. It is known that uric acid is an end metabolite of purine degradation in humans, but in other species from <em>D. melanogaster </em>to lower apes,<em> </em>uric acid can be further metabolized by urate oxidase into readily excreted allantoin. We hypothesize that if urate oxidase enzyme activity and dietary purine are both critical in uric acid kidney stone formation, then urate oxidase knockdown in combination with dietary purine supplementation will increase uric acid and induce uric acid kidney stone formation in <em>D. melanogaster</em>. Initially, we confirmed urate oxidase knockdown and then elevation of uric acid as a consequence. We then confirmed uric acid kidney stones formed as a consequence of urate oxidase knocked down and a high purine diet. Next, we tested compounds used to treat gout or uric acid kidney stones in humans using our model. We found that allopurinol and potassium citrate reduced uric acid kidney stone formation in our model. We then tested whether compounds predicted to reduce uric acid and uric acid kidney stones in humans, but not currently used as treatments, can reduce uric acid kidney stone formation in our model. We found that methotrexate, hydrochlorothiazide, and l-lysine were effective at reducing uric acid kidney stone formation. Lastly, we ran a medium throughput screen of 117 natural compounds for inhibitors of uric acid kidney stone formation using our model and found seven inhibitors.</p>"]},{"key":"dc:title","label":"Title","values":["Modeling Uric Acid Kidney Stones Disease in D. melanogaster using RNAi and Dietary Modulation"]}]}],"canonical_facts":{"dc:contributor":["Pankah Kapahi, PhD","Roland Cooper, PhD"],"dc:creator":["Lu, Hai T.H."],"dc:date.available":["2019-05-14T07:00:00Z"],"dc:description.abstract":["<p>In humans, the major predictor for gout and forming uric acid kidney stones is elevated uric acid in the serum and urine respectively. It is known that uric acid is an end metabolite of purine degradation in humans, but in other species from <em>D. melanogaster </em>to lower apes,<em> </em>uric acid can be further metabolized by urate oxidase into readily excreted allantoin. We hypothesize that if urate oxidase enzyme activity and dietary purine are both critical in uric acid kidney stone formation, then urate oxidase knockdown in combination with dietary purine supplementation will increase uric acid and induce uric acid kidney stone formation in <em>D. melanogaster</em>. Initially, we confirmed urate oxidase knockdown and then elevation of uric acid as a consequence. We then confirmed uric acid kidney stones formed as a consequence of urate oxidase knocked down and a high purine diet. Next, we tested compounds used to treat gout or uric acid kidney stones in humans using our model. We found that allopurinol and potassium citrate reduced uric acid kidney stone formation in our model. We then tested whether compounds predicted to reduce uric acid and uric acid kidney stones in humans, but not currently used as treatments, can reduce uric acid kidney stone formation in our model. We found that methotrexate, hydrochlorothiazide, and l-lysine were effective at reducing uric acid kidney stone formation. Lastly, we ran a medium throughput screen of 117 natural compounds for inhibitors of uric acid kidney stone formation using our model and found seven inhibitors.</p>"],"dc:identifier":["https://scholar.dominican.edu/masters-theses/178"],"dc:subject":["uric acid kidney stones","nephrolithiasis","biomineralization","purine metabolism","drosophila melanogaster","translational animal model","Integrative Biology"],"dc:title":["Modeling Uric Acid Kidney Stones Disease in D. melanogaster using RNAi and Dietary Modulation"],"thesis:degree_discipline":["Biological Sciences"],"thesis:degree_level":["Master's Thesis"],"thesis:degree_name":["Master of Science"]},"updated_at":"2026-07-24T02:04:35Z"}